Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Outcome of Simultaneous Transurethral Resection of Bladder Tumor and Transurethral Resection of the Prostate in Comparison with the Procedures in Two Separate Sittings in Patients with Bladder Tumor and Urodynamically Proven Bladder Outflow Obstruction
Journal of Endourology, 10/27/09
Singh V et al. – TURBT and TURP can be performed simultaneously without any increased risk of recurrence and progression of tumor, if performed in a properly selected group of patients.
Related Articles
Combined Analysis of Smoking, TP53 , and FGFR3 Mutations in Tunisian Patients with Invasive and Superficial High-Grade Bladder Tumors
Cancer Investigation, 11/16/09
Relevance Score: 69%
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: Results in 1005 patients
Annals of Oncology, 11/10/09
Relevance Score: 68%
A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder
Urologic Oncology: Seminars and Original Investigations, 10/26/09
Relevance Score: 68%
Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 67%
Perivesical Inflammation and Necrosis due to Mitomycin C Instillation after Transurethral Resection of Bladder Tumor: We Must Be Vigilant!
Urologia Internationalis, 10/26/09
Relevance Score: 67%
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men
BJU International, 12/09/09
Physical therapy for premature ejaculation, erectile dysfunction and chronic pelvic pain syndrome
BJU International, 12/09/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Physical therapy for premature ejaculation, erectile dysfunction and chronic pelvic pain syndrome
BJU International, 12/09/09
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men
BJU International, 12/09/09
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/09/09
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Current status of robot-assisted radical cystectomy
Current Opinion in Urology, 12/09/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Journal of Clinical Oncology, 12/09/09
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
Does the combination of an [alpha]1-adrenergic antagonist with a 5[alpha]-reductase inhibitor improve urinary symptoms more than either monotherapy
Current Opinion in Urology, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


